Science, Discovery, Tech and Environment · 22 October 2026
FDA Approves Generic Estradiol and Levonorgestrel Transdermal System for Women
Exam-focused facts from the 22 October 2026 current affairs briefing.
Key facts
- The U.S. Food and Drug Administration approved the Estradiol and Levonorgestrel Transdermal System manufactured by Zydus Pharmaceuticals USA Inc.
- The transdermal patch contains both estrogen and progestogen in a single formulation, differing from estrogen-only patches.
- The medication is specifically approved for women with an intact uterus to reduce the risk of endometrial hyperplasia.
- The transdermal hormone therapy patch is designed to be applied once a week.
- The generic system is therapeutically equivalent to Climara Pro, which is a registered trademark of Bayer.